+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Botulinum Toxin - Global Strategic Business Report

  • PDF Icon

    Report

  • 353 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 516890

Global Botulinum Toxin Market to Reach $11 Billion by 2030

The global market for Botulinum Toxin estimated at US$5.6 Billion in the year 2022, is projected to reach a revised size of US$11 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2022-2030. Type A, one of the segments analyzed in the report, is projected to record 8.8% CAGR and reach US$11 Billion by the end of the analysis period. Growth in the Type B segment is estimated at 7.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 16% CAGR

The Botulinum Toxin market in the U.S. is estimated at US$3.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 16% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.6% and 7.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Select Competitors (Total 28 Featured) -

  • AbbVie Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Evolus, Inc.
  • Galderma SA
  • Daewoong Pharmaceutical Co., Ltd.
  • Revance Therapeutics, Inc.
  • Protox Co., Ltd.
  • Medy-Tox
  • Jetema Co., Ltd.
  • Hugel, Inc.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Frequently Asked Questions about the Botulinum Toxin Market

What is the estimated value of the Botulinum Toxin Market?

The Botulinum Toxin Market was estimated to be valued at $5.6 Billion in 2022.

What is the growth rate of the Botulinum Toxin Market?

The growth rate of the Botulinum Toxin Market is 8.8%, with an estimated value of $11 Billion by 2030.

What is the forecasted size of the Botulinum Toxin Market?

The Botulinum Toxin Market is estimated to be worth $11 Billion by 2030.

Who are the key companies in the Botulinum Toxin Market?

Key companies in the Botulinum Toxin Market include AbbVie Inc., Merz Pharma GmbH & Co. KGaA, Evolus, Inc., Galderma SA, Daewoong Pharmaceutical Co., Ltd., Revance Therapeutics, Inc., Protox Co., Ltd., Medy, Tox and Jetema Co., Ltd..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • COVID-19 Disruptions Impact Botulinum Toxin Business
  • Virtual Care to the Fore amid COVID-19
  • Aesthetic Clinics to Follow Infection-Prevention Measures to Mitigate Risk of COVID-19 Infection Transmission
  • % Rise in Migraine Attacks due to COVID-19 Pandemic for March 2020
  • COVID-19 Disruptions Highlight Significance of Botulinum Toxin Therapy for Associated Medical Conditions
  • Researchers Eye on Botulinum Toxin as Potential Therapeutic Option to Alleviate and Manage COVID-19 Infection
  • Botulinum Toxin - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Botulinum Toxin: An Introduction
  • Outlook
  • Therapeutic BTX Applications Lead
  • Cosmetic BTX Gradually Gains Momentum
  • Factors Propelling the Cosmetic BT Market: In a Nut Shell
  • Percent of Plastic Surgeons Performing Botulinum Toxin Surgical Procedures in Select Countries: 2019
  • Developed Regions Dominate Botulinum Toxin Market
  • Developing Markets to Drive Future Growth
  • Competitive Landscape
  • Intense Competition Characterizes Botulinum Toxin Market
  • Market Share of Leading Players in Global Botulinum Toxin Market: 2019
  • Select Approved Botulinum Toxin Products Worldwide
  • Companies Entering the Fray
  • Pharma Companies Eye Lucrative BT Market
  • Biosimilar BTX Variants Challenge Botox’s Leadership
  • Lack of Differentiation among Approved BTX Products
  • Comparison of Leading Neurotoxins - Botox, Dysport and Xeomin by Safety and Efficacy
  • Comparison of Botox®, Dysport® and Xeomin® by Indications and Year of Approval
  • BOTOX®
  • Approvals and Indications of Botox in Select Regions
  • Botox Therapeutic Approvals in the US by Indication
  • Ipsen Counts on New Indications for Future Growth of Dysport
  • Xeomin®
  • Merz
  • Other Products
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Non-Invasive Cosmetic Treatments Bodes Well for BTX Market
  • Non-Surgical Cosmetic Procedures Worldwide (2018): Percentage Breakdown of Procedure Volumes
  • Botulinum Toxin: The Preferred Solution in Facial Injectables Market
  • Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Gender
  • Millennials: A Popular Demographic for Botulinum Toxin
  • Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Age Group Age Group % Share
  • Therapeutic Areas and Opportunities
  • Botox Therapeutic Applications Uses and Indications
  • Global Therapeutic BTX Neurotoxin Market Breakdown by Therapeutic Indication (2019)
  • Botulinum Toxin Remains Gold Standard for Treatment of Focal Spasticity
  • Rise in the Number of Musculoskeletal Indications: Potential for Growth
  • Unmet Medical Needs Encourage Off-Label Use: A Cause for Concern or Jubilation?
  • Combination Therapies: A Double Whammy Success
  • Botulinum Toxin: Potential Applications in Treatment of Dental Diseases
  • Potential Applications in Dentistry
  • Short-lived Aesthetic Effects: A Strong Business Case for Revision Treatments
  • Novel Injection Systems for Highly Precise Dosage of Botulinum Toxin
  • Longer Life Expectancy and Rising Disposable Incomes Propel Sales of Cosmetic BTX
  • Life Expectancy at Birth in Years of People in Select Countries
  • Life Expectancy at Birth (in Years) of Men and Women by Region
  • Increase in Healthcare Spending Stirs Demand for BTX in Therapeutic Applications
  • Current Health Expenditure (CHE) as Percentage Of Gross Domestic Product (GDP) (%): 2017
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Challenges and Issues
  • Undesirable Side Effects: A Challenge to Reckon With
  • Immunogenicity Undermines Patient Compliance
  • Antigenicity: A Problematic Issue in Drug Development
  • Potential Adverse Side Effects: A Major Barrier to Success
  • Stringent Regulations Delay Market Approvals
  • Higher Product Costs to Challenge Market Growth
  • Consumer Skepticism: The Biggest Challenge to Beat
  • Animal Cruelty:A Part & Parcel of Botox Testing
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Type A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Type B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Aesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Specialty & Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
  • Table 25: World Botulinum Toxin Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Market Overview
  • Opportunities in Store for Cosmetic BTX
  • Age-wise Distribution for Botulinum Toxin Procedures Performed in the US for the Year 2019
  • Gender Distribution for Botulinum Toxin Procedures Performed in the US (2019)
  • Increasing Demand for Cosmetic Treatments Bodes Well for BTX Market
  • Cosmetic Procedures: Facts and Figures
  • Number of Surgical & Non-Surgical Cosmetic Procedures ('000s) in the US for the Years 2000, 2018 & 2019
  • Top 5 Surgical Cosmetic Procedures in the US - Ranked by the Number of Procedures Performed (In ‘000s) for 2019
  • Top 4 Non-Surgical Cosmetic Procedures in the US - Ranked by the Number of Procedures Performed (‘000s) for 2019
  • Number of Botulinum Toxin Procedures* Performed in the US: 2000, 2016 and 2019
  • Aging Baby Boomers Drive Aesthetic Business
  • US Population by Age Group (2017): Percentage Breakdown for 0-14, 15-24, 25-59 and 65+ Age Groups
  • North American Aging Population by Age Group: 1975-2050
  • Expanding Physician Base Extends Impetus to Growth
  • Therapeutic BTX Seeks Growth Opportunities
  • Approved Therapeutic Indications of Botulinum Toxin in the US by Year of Approval
  • Neurogenic OAB: A Lucrative Market Opportunity
  • Competitive Landscape
  • Major BTX Products and Associated Fillers in the Cosmetic Botulinum Toxin Market
  • Market Share of Leading Brands in the US Boulinum Toxin Market: 2019
  • Dysport Poses Strong Competition to Botox in the Therapeutic Space
CANADA
JAPAN
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Market Overview
  • Non-Surgical Aesthetic Procedures in Japan (2019): Percentage Breakdown of Number of Procedures by Procedure Type Procedure % Share
CHINA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Market Overview
  • Uptrend in Facial Injectables Market Favors Market Expansion
  • Regulatory Scenario
  • Approved Botulinum Toxin Injections in China
  • Competition
  • Market Share of Leading Players in Chinese Botulinum Toxin Market: 2019
EUROPE
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Market Overview
  • Botox Approvals and Indications in Select European Countries
  • Non-Surgical Aesthetic Procedures in Select European Countries (2019): Percentage Breakdown of Number of Procedures by Procedure Type
  • Regulations for Botulinum Toxin Usage in the EU
FRANCE
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Market Overview
  • Snapshots
SPAIN
RUSSIA
  • Market Overview
REST OF EUROPE
ASIA-PACIFIC
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • Market Overview
  • Non-Surgical Aesthetic Procedures in Australia (2019): Percentage Breakdown of Number of Procedures by Procedure Type
INDIA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • Market Overview
  • Non-Surgical Aesthetic Procedures in India (2019): Percentage Breakdown of Number of Procedures by Procedure Type
SOUTH KOREA
  • Market Overview
  • Strong Demand for Cosmetic Procedures - Potential for BTX Market
  • Working Women as % of Total Female Population for 2005, 2010, 2015 & 2018
  • Foreign Patients Visiting Korea for Plastic Surgery & Dermatology Procedures as a % of Total Visits of Foreign Patients
  • Competition
  • Market Share of Leading Players in Botulinum Toxin Market In South Korea
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Evolus, Inc.
  • Galderma SA
  • Daewoong Pharmaceutical Co., Ltd.
  • Revance Therapeutics, Inc.
  • Protox Co., Ltd.
  • Medy-Tox
  • Jetema Co., Ltd.
  • Hugel, Inc.